BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borisovna KO, Yurievna KA, Yurievich TK, Igorevna KO, Olegovich KD, Igorevna DA, Timofeevna BT, Vyacheslavovna ZN, Ivanovna SE, Alekseevich SP, Vladimirovich IV. Compound heterozygous POMGNT1 mutations leading to muscular dystrophy-dystroglycanopathy type A3: a case report. BMC Pediatr 2019;19:98. [PMID: 30961548 DOI: 10.1186/s12887-019-1470-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Mohammadi P, Daneshmand MA, Mahdieh N, Ashrafi MR, Heidari M, Garshasbi M. Identification of a novel missense c.386G > A variant in a boy with the POMGNT1-related muscular dystrophy-dystroglycanopathy. Acta Neurol Belg 2021;121:143-51. [PMID: 33175337 DOI: 10.1007/s13760-020-01527-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Mohamadian M, Rastegar M, Pasamanesh N, Ghadiri A, Ghandil P, Naseri M. Clinical and Molecular Spectrum of Muscular Dystrophies (MDs) with Intellectual Disability (ID): a Comprehensive Overview. J Mol Neurosci 2021. [PMID: 34727324 DOI: 10.1007/s12031-021-01933-4] [Reference Citation Analysis]
3 Arvio M, Määttänen L, Haanpää M, Lähdetie J. Two middle-aged women with the Finnish variant of muscle-eye-brain disease (MEB). Am J Med Genet A 2019;179:2481-5. [PMID: 31580529 DOI: 10.1002/ajmg.a.61369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Kritioti E, Theodosiou A, Parpaite T, Alexandrou A, Nicolaou N, Papaevripidou I, Séjourné N, Coste B, Christophidou-Anastasiadou V, Tanteles GA, Sismani C. Unravelling the genetic causes of multiple malformation syndromes: A whole exome sequencing study of the Cypriot population. PLoS One 2021;16:e0253562. [PMID: 34324503 DOI: 10.1371/journal.pone.0253562] [Reference Citation Analysis]